An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

NCT00250627 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
465
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi